01 / RECURRING REVENUE
Clear subscription model
Free entry, then Plus at $10 and Pro at $20 per month. Recurring paying customers, retention and contribution margins are the core measures of progress.
Famocare · Investor overview
Backing the next stage of Famocare.
An investment-focused overview of the capital plan, subscription economics and milestones behind Famocare’s next stage of growth.
$10 / $20Plus / Pro monthly subscriptions
$12Illustrative gross revenue per paid user / month*
$2Monthly continuing-referral reward per eligible subscription
1,000+Paying-customer milestone for next funding discussion
Investment rationale
A disciplined approach to early-stage growth.
Investors can review the product on famocare.com. Here, the focus is the business model, funding discipline and path to measurable traction.
02 / DISTRIBUTION
Referral-led acquisition
The built-in referral system is both a product growth capability and an acquisition channel: eligible referrers earn $2 monthly while a referred subscription continues.
03 / CAPITAL DISCIPLINE
Fund against evidence
Capital is intended to support product quality, measurable customer acquisition and operations. Any later raise depends on paid traction, retention and acquisition efficiency.
Funding roadmap
Two stages. One measured growth plan.
The Seed stage is the current priority. Growth & Scale is a possible future financing stage—not an automatic or committed investment round.
Target 1 · SeedCurrent planning priority
Launch, Validate & Convert
$50,000
Proposed funding target
Funding intended for launch execution, product improvements, customer acquisition and core operations. Progress is measured through paid customers, retention and cash efficiency.
$500KProposed post-money business value
10%Indicative new investor equity
1,000+Paying customers at success
$12KGross monthly revenue at success
$0Net monthly operating income
0%Operating profit margin
Target 2 · Growth & ScaleFuture, conditional
Expand what works.
$150,000
Indicative later funding target
A potential follow-on stage after 1,000+ verified paying customers, healthy retention and demonstrated acquisition economics. Long-term aspiration: 10,000 paying customers, without assuming another raise is necessary.
$1MProposed post-money business value
15%Indicative new investor equity
10,000+Paying customers at success
$120KGross monthly revenue at success
$60KNet monthly operating income
50%Operating profit margin
Indicative figures only: The business values shown are proposed post-money financing valuations, not independently appraised values. Equity percentages assume fully subscribed priced rounds and no other dilution. The 0% and 50% figures are projected pre-tax business operating margins, not investor profit distributions or guaranteed returns. No shares are offered through this public page; all actual terms require legal review, eligibility checks and definitive private documentation.
Unit economics
Two targets. A transparent financial plan.
Target 1 is Launch, Validate & Convert, reaching 1,000 paying customers and operating break-even. Target 2 is Growth & Scale, reaching 10,000 paying customers and a modeled $60,000 monthly operating income. These are planning targets, not current performance or guaranteed results.
$12.00Illustrative gross monthly revenue per paying customer
0%Target 1 · projected operating profit margin at success (break-even)
50%Target 2 · projected operating profit margin at success
| Monthly cost distribution & income | Target 1 · Launch, Validate & ConvertAfter success · 1,000 paying customers | Target 2 · Growth & ScaleAfter success · 10,000 paying customers |
|---|---|---|
| Paying customers | 1,000 | 10,000 |
| Illustrative average monthly revenue / customer | $12 | $12 |
| Gross monthly income | $12,000 | $120,000 |
| Store commissions (15% modeled) | −$1,800 | −$18,000 |
| Referral rewards (50% of subscribers) | −$1,000 | −$10,000 |
| Paid-user AI & infrastructure | −$1,200 | −$12,000 |
| Development | −$3,000 | −$6,000 |
| Operations | −$2,000 | −$4,000 |
| Acquisition | −$3,000 | −$10,000 |
| Total monthly expenses | −$12,000 | −$60,000 |
| Illustrative monthly operating income after success | $0 | +$60,000 |
| Illustrative operating margin after success | 0% | 50.0% |
Before Target 1 success: the launch-period budget assumes $0 gross income and $8,000 monthly spending, consisting of $3,000 Development, $2,000 Operations, and $3,000 Acquisition. That represents a monthly operating loss of $8,000 before customer revenue. After reaching 1,000 paying customers, modeled subscription-variable expenses rise to $4,000 and total costs to $12,000, producing break-even. The illustration assumes $12 average gross subscription revenue per customer, 15% effective platform fee (not guaranteed), 50% referred subscribers at $2 each/month, and $1.20 average paid-user AI/server cost. If platform fees are 30% instead, monthly operating income would be approximately −$1,800 at Target 1 and +$42,000 at Target 2. Figures are pre-tax operating estimates, not verified profit; refunds, additional payroll, marketing and other expenses could reduce results.
Seed capital allocation
Every dollar has a job.
A proposed allocation of the first $50,000. Actual deployment should be updated from the operating budget and validated acquisition economics before financing closes.
1
Launch & retentionTest activation, paid conversion and ongoing usage.
2
Repeatable acquisitionMeasure CAC, referral cohorts and payback.
3
Ready for Growth & ScaleValidate 1,000+ paying users and a sustainable cost structure.
Marketing & customer acquisition45% · $22,500
Product development & AI25% · $12,500
Operations & infrastructure20% · $10,000
Contingency reserve10% · $5,000
Illustrative budget only; no representation that $50K is sufficient to reach the paying-customer milestone without additional operating cash flow.
Founder & execution
Founder-led, with an existing development organization.
Famocare is currently developed through Appistan Software House (Private) Limited in Pakistan. Upon securing suitable investment commitments, we plan to establish a new U.S.-based Famocare company to receive investment and operate the independent product business.
Incorporation, U.S. and Pakistani legal/tax compliance, shareholder structure and transfer or licensing of Appistan-owned Famocare intellectual property will be completed before the new company accepts investment funds or issues shares. No U.S. Famocare company has been formed yet.
Investor enquiries
Start a private conversation.
Interested in the Seed financing strategy? Register your interest or request an introductory meeting. Investor suitability, the legal issuer and any terms will be reviewed privately before documents or payment instructions are issued.
01Share basic investor details and your preferred conversation.
02The team reviews fit and applicable investor eligibility requirements.
03If appropriate, arrange a meeting and share legally reviewed private materials.
Investor interest form
No investment is accepted through this website.